Recent News

• 06.10.2025 - XPro™ Reduces Amyloid and Enhances Behavior Post Traumatic Brain Injury in an Animal Model of Alzheimer’s Disease: Supported by Department of Defense
• 05.14.2025 - INmune Bio Inc. Announces Attendance at the 2025 RBC Capital Markets Global Healthcare Conference
• 05.08.2025 - INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update
• 05.05.2025 - INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th
• 04.16.2025 - INmune Bio Receives Favorable Patentability Opinion for CORDStrom™ Platform Technology

Recent Filings

• 06.10.2025 - EX-99.1 EX-99.1
• 06.10.2025 - 8-K Current report
• 05.14.2025 - 8-K Current report
• 05.14.2025 - EX-99.1 EX-99.1
• 05.09.2025 - DEFR14A Revised definitive proxy soliciting materials
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.08.2025 - 8-K Current report
• 05.08.2025 - EX-99.1 EX-99.1
• 05.07.2025 - 8-K Current report
• 05.05.2025 - EX-99.1 EX-99.1